Holdings of Euclidean Capital LLC
9 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Funds 4.4 %
- Unattributed 95.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 9 | 392.3M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US ETF | 3,243,484 | 243.6M $ | |
| 2 | Vanguard Value ETF | 520,000 | 102M $ | |
| 3 | iShares Trust | 369,600 | 17.3M $ | |
| 4 | ORIC Pharmaceuticals Inc | 989,410 | 12.5M $ | |
| 5 | Foghorn Therapeutics Inc | 1,573,761 | 7.5M $ | |
| 6 | PMV Pharmaceuticals Inc | 2,627,643 | 3.3M $ | |
| 7 | Alector Inc | 1,307,858 | 2.8M $ | |
| 8 | Surrozen Inc | 87,696 | 2.6M $ | |
| 9 | Tenaya Therapeutics Inc | 1,015,705 | 703.3K $ |